Logo image of BV

BRIGHTVIEW HOLDINGS INC (BV) Stock Fundamental Analysis

USA - NYSE:BV - US10948C1071 - Common Stock

13.34 USD
-0.23 (-1.69%)
Last: 9/17/2025, 8:27:31 PM
13.34 USD
0 (0%)
After Hours: 9/17/2025, 8:27:31 PM
Fundamental Rating

3

BV gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 84 industry peers in the Commercial Services & Supplies industry. Both the profitability and financial health of BV have multiple concerns. BV is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

BV had positive earnings in the past year.
BV had a positive operating cash flow in the past year.
In multiple years BV reported negative net income over the last 5 years.
Each year in the past 5 years BV had a positive operating cash flow.
BV Yearly Net Income VS EBIT VS OCF VS FCFBV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M 200M

1.2 Ratios

BV has a Return On Assets of 0.21%. This is comparable to the rest of the industry: BV outperforms 42.86% of its industry peers.
BV has a Return On Equity (0.39%) which is comparable to the rest of the industry.
BV has a Return On Invested Capital (3.13%) which is in line with its industry peers.
The Average Return On Invested Capital over the past 3 years for BV is significantly below the industry average of 10.60%.
The last Return On Invested Capital (3.13%) for BV is above the 3 year average (2.40%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 0.21%
ROE 0.39%
ROIC 3.13%
ROA(3y)0.26%
ROA(5y)0.17%
ROE(3y)0.6%
ROE(5y)0.4%
ROIC(3y)2.4%
ROIC(5y)2.06%
BV Yearly ROA, ROE, ROICBV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 -4 -6

1.3 Margins

The Profit Margin of BV (0.26%) is comparable to the rest of the industry.
BV's Profit Margin has declined in the last couple of years.
With a Operating Margin value of 4.88%, BV perfoms like the industry average, outperforming 46.43% of the companies in the same industry.
In the last couple of years the Operating Margin of BV has declined.
BV's Gross Margin of 23.25% is on the low side compared to the rest of the industry. BV is outperformed by 65.48% of its industry peers.
BV's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.88%
PM (TTM) 0.26%
GM 23.25%
OM growth 3Y4.93%
OM growth 5Y-5.36%
PM growth 3Y-27.02%
PM growth 5Y-17.52%
GM growth 3Y-2.9%
GM growth 5Y-2.54%
BV Yearly Profit, Operating, Gross MarginsBV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BV is destroying value.
The number of shares outstanding for BV has been increased compared to 1 year ago.
BV has less shares outstanding than it did 5 years ago.
The debt/assets ratio for BV has been reduced compared to a year ago.
BV Yearly Shares OutstandingBV Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BV Yearly Total Debt VS Total AssetsBV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 1.46, we must say that BV is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of BV (1.46) is worse than 66.67% of its industry peers.
BV has a debt to FCF ratio of 24.18. This is a negative value and a sign of low solvency as BV would need 24.18 years to pay back of all of its debts.
The Debt to FCF ratio of BV (24.18) is comparable to the rest of the industry.
A Debt/Equity ratio of 0.44 indicates that BV is not too dependend on debt financing.
BV has a Debt to Equity ratio of 0.44. This is comparable to the rest of the industry: BV outperforms 55.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 24.18
Altman-Z 1.46
ROIC/WACC0.38
WACC8.16%
BV Yearly LT Debt VS Equity VS FCFBV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

BV has a Current Ratio of 1.31. This is a normal value and indicates that BV is financially healthy and should not expect problems in meeting its short term obligations.
BV has a Current ratio of 1.31. This is in the lower half of the industry: BV underperforms 65.48% of its industry peers.
A Quick Ratio of 1.31 indicates that BV should not have too much problems paying its short term obligations.
The Quick ratio of BV (1.31) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.31
Quick Ratio 1.31
BV Yearly Current Assets VS Current LiabilitesBV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

4

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 21.88% over the past year.
Measured over the past years, BV shows a decrease in Earnings Per Share. The EPS has been decreasing by -8.19% on average per year.
Looking at the last year, BV shows a decrease in Revenue. The Revenue has decreased by -2.99% in the last year.
BV shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.85% yearly.
EPS 1Y (TTM)21.88%
EPS 3Y-14.5%
EPS 5Y-8.19%
EPS Q2Q%-6.25%
Revenue 1Y (TTM)-2.99%
Revenue growth 3Y2.71%
Revenue growth 5Y2.85%
Sales Q2Q%-4.13%

3.2 Future

The Earnings Per Share is expected to grow by 12.15% on average over the next years. This is quite good.
Based on estimates for the next years, BV will show a small growth in Revenue. The Revenue will grow by 1.47% on average per year.
EPS Next Y9.87%
EPS Next 2Y8.93%
EPS Next 3Y12.15%
EPS Next 5YN/A
Revenue Next Year-2.64%
Revenue Next 2Y-0.3%
Revenue Next 3Y1.47%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
BV Yearly Revenue VS EstimatesBV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 500M 1B 1.5B 2B 2.5B
BV Yearly EPS VS EstimatesBV Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

4

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 17.10, BV is valued on the expensive side.
73.81% of the companies in the same industry are more expensive than BV, based on the Price/Earnings ratio.
The average S&P500 Price/Earnings ratio is at 27.20. BV is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 14.99, BV is valued correctly.
BV's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. BV is cheaper than 75.00% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of BV to the average of the S&P500 Index (22.70), we can say BV is valued slightly cheaper.
Industry RankSector Rank
PE 17.1
Fwd PE 14.99
BV Price Earnings VS Forward Price EarningsBV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BV is valued cheaply inside the industry as 86.90% of the companies are valued more expensively.
The rest of the industry has a similar Price/Free Cash Flow ratio as BV.
Industry RankSector Rank
P/FCF 38.71
EV/EBITDA 6.84
BV Per share dataBV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as BV's earnings are expected to grow with 12.15% in the coming years.
PEG (NY)1.73
PEG (5Y)N/A
EPS Next 2Y8.93%
EPS Next 3Y12.15%

0

5. Dividend

5.1 Amount

BV does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BRIGHTVIEW HOLDINGS INC

NYSE:BV (9/17/2025, 8:27:31 PM)

After market: 13.34 0 (0%)

13.34

-0.23 (-1.69%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)08-06 2025-08-06/amc
Earnings (Next)11-11 2025-11-11/amc
Inst Owners72.37%
Inst Owner Change1.82%
Ins Owners3.06%
Ins Owner Change-0.49%
Market Cap1.27B
Analysts80
Price Target19.6 (46.93%)
Short Float %6.86%
Short Ratio5.46
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.19
Dividend Growth(5Y)N/A
DP511.43%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)4.42%
Min EPS beat(2)-13.06%
Max EPS beat(2)21.9%
EPS beat(4)2
Avg EPS beat(4)1.55%
Min EPS beat(4)-13.06%
Max EPS beat(4)21.9%
EPS beat(8)3
Avg EPS beat(8)-4.95%
EPS beat(12)6
Avg EPS beat(12)7.79%
EPS beat(16)7
Avg EPS beat(16)3.06%
Revenue beat(2)0
Avg Revenue beat(2)-2.8%
Min Revenue beat(2)-5.2%
Max Revenue beat(2)-0.41%
Revenue beat(4)0
Avg Revenue beat(4)-3.15%
Min Revenue beat(4)-5.2%
Max Revenue beat(4)-0.41%
Revenue beat(8)0
Avg Revenue beat(8)-3.58%
Revenue beat(12)1
Avg Revenue beat(12)-2.88%
Revenue beat(16)2
Avg Revenue beat(16)-2.01%
PT rev (1m)0.07%
PT rev (3m)-2.4%
EPS NQ rev (1m)0.71%
EPS NQ rev (3m)-8.21%
EPS NY rev (1m)-6.49%
EPS NY rev (3m)-5.01%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-5.97%
Revenue NY rev (1m)-1.07%
Revenue NY rev (3m)-3.38%
Valuation
Industry RankSector Rank
PE 17.1
Fwd PE 14.99
P/S 0.47
P/FCF 38.71
P/OCF 4.85
P/B 0.71
P/tB N/A
EV/EBITDA 6.84
EPS(TTM)0.78
EY5.85%
EPS(NY)0.89
Fwd EY6.67%
FCF(TTM)0.34
FCFY2.58%
OCF(TTM)2.75
OCFY20.61%
SpS28.44
BVpS18.83
TBVpS-3.19
PEG (NY)1.73
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.21%
ROE 0.39%
ROCE 4.62%
ROIC 3.13%
ROICexc 3.22%
ROICexgc 13.12%
OM 4.88%
PM (TTM) 0.26%
GM 23.25%
FCFM 1.21%
ROA(3y)0.26%
ROA(5y)0.17%
ROE(3y)0.6%
ROE(5y)0.4%
ROIC(3y)2.4%
ROIC(5y)2.06%
ROICexc(3y)2.47%
ROICexc(5y)2.14%
ROICexgc(3y)10.98%
ROICexgc(5y)10.41%
ROCE(3y)3.54%
ROCE(5y)3.05%
ROICexcg growth 3Y-0.5%
ROICexcg growth 5Y-6.24%
ROICexc growth 3Y6.57%
ROICexc growth 5Y-3.78%
OM growth 3Y4.93%
OM growth 5Y-5.36%
PM growth 3Y-27.02%
PM growth 5Y-17.52%
GM growth 3Y-2.9%
GM growth 5Y-2.54%
F-Score5
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF 24.18
Debt/EBITDA 2.71
Cap/Depr 142.18%
Cap/Sales 8.46%
Interest Coverage 2.68
Cash Conversion 89.32%
Profit Quality 467.14%
Current Ratio 1.31
Quick Ratio 1.31
Altman-Z 1.46
F-Score5
WACC8.16%
ROIC/WACC0.38
Cap/Depr(3y)57.78%
Cap/Depr(5y)51.34%
Cap/Sales(3y)3.08%
Cap/Sales(5y)2.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)21.88%
EPS 3Y-14.5%
EPS 5Y-8.19%
EPS Q2Q%-6.25%
EPS Next Y9.87%
EPS Next 2Y8.93%
EPS Next 3Y12.15%
EPS Next 5YN/A
Revenue 1Y (TTM)-2.99%
Revenue growth 3Y2.71%
Revenue growth 5Y2.85%
Sales Q2Q%-4.13%
Revenue Next Year-2.64%
Revenue Next 2Y-0.3%
Revenue Next 3Y1.47%
Revenue Next 5YN/A
EBIT growth 1Y14.04%
EBIT growth 3Y7.78%
EBIT growth 5Y-2.67%
EBIT Next Year77.78%
EBIT Next 3Y27.2%
EBIT Next 5YN/A
FCF growth 1Y-38.76%
FCF growth 3Y13.41%
FCF growth 5Y9.77%
OCF growth 1Y99.92%
OCF growth 3Y11.48%
OCF growth 5Y3.91%